5500 Analyzer
Back to filter
Original filing (PDF)20251013142313NAL0002173088003

NORTHWEST ONCOLOGY & HEMATOLOGY,S.C

Form 5500
FILING_RECEIVED
NORTHWEST ONCOLOGY & HEMATOLOGY, S.C. PROFIT SHARING 401(K) PLAN
401(k) retirement plan
Signals · 2
29% in single holdingNo recordkeeper disclosed
Active participants
165
Accounts w/ balance
175
Plan assets (EOY)
$30.2M
Net assets (EOY)
$30.2M
How this plan invests
This plan
31 securities
funds · stocks · CUSIPs

Holdings are itemized directly on this plan's Schedule of Assets, below.

Plan health score (directional)
89
/ 100
Grade A
Top-tier plan health
Directional indicator computed from public Form 5500 data — compliance, concentration, cost, vendor stack and participation. Not a fiduciary tool.
Compliance & disclosures
100
Concentration risk
86
Total plan cost
75
Vendor stack
80
Participation health
100
Knocking points off
  • Top holding "Vanguard 500 Index Fd As Mutual Fund ^" is 29% of plan.
  • No recordkeeper disclosed on Schedule C.
Helping the score
  • No Schedule C compensation disclosed — likely a small plan or unbundled.
Decision-maker contacts
CFO / Head of HR / Benefits Manager — verified email + LinkedIn for NORTHWEST ONCOLOGY & HEMATOLOGY,S.C.
Plan sponsor
Name
NORTHWEST ONCOLOGY & HEMATOLOGY,S.C
EIN
36-3395596
Address
3701 ALGONQUIN RD. SUITE 900 · ROLLING MEADOWS, IL · 60008
Phone
(847) 577-0620
Industry
Health Care & Social Assistancesee all
Plan administrator
Same as plan sponsor.
Plan characteristics
Plan number
001
Plan year
2024
Plan year begin
2024-01-01
Tax period
2024-12-31
Filed
2025-10-13
Pension benefit codes
2E · Profit-sharing
2F · ERISA section 404(c)
2G · Total participant-directed accounts
2J · 401(k) feature
2K · 401(m) arrangement
2S · Automatic enrollment
2T · Default investment account (QDIA)
3D · Pre-approved plan (master / prototype / VS)
Audit & trust (Schedule H)
Auditor
CJBS,LLC
Trustee / custodian
Trustee phone

Service providers (Schedule C)

No Schedule C providers reported

Investments

31 direct securities· $30.2M(100% of reported assets)
PIInvestmentTypeShares / unitsCostCurrent value% of plan
Vanguard 500 Index Fd As Mutual Fund ^$8.6M28.6%
American Funds US Government Sec R6 Mutual Fund ^$3.4M11.4%
Vangard Val Index Admiral Mutual Fund ^$3.4M11.1%
JPM Large Cap Growth R6 Mutual Fund ^$2.9M9.6%
Loomis Sayles Core Plis Bond Mutual Fund ^$2.4M8.0%
Vanguard Mid Cap Value Index Admiral Mutual Fund ^$1.9M6.4%
Vangard St Corp Bond Mutual Fund ^$929K3.1%
American Funds Europacific Growth R6 Mutual Fund ^$803K2.7%
Vanguard Small Cap Value Index Admiral Mutual Fund ^$788K2.6%
BlackRock Health Sciences Opps Inv A Mutual Fund ^$554K1.8%
Fidelity Puritan Mutual Fund ^$543K1.8%
Vangard Info Tech Mutual Fund ^$489K1.6%
American Funds New Prospect R6 Mutual Fund ^$427K1.4%
Vanguard Small Cap Growth Index Admiral Mutual Fund ^$426K1.4%
and due at various dates through October * Notes Receivable from Participants 2029 -$355K1.2%
American Funds Target Date 2030 Mutual Fund ^$340K1.1%
American Funds Target Date 2045 Mutual Fund ^$324K1.1%
American Funds Target Date 2065 Mutual Fund ^ 250 Carlin Eagle Mid Cao Mutual Fund ^$304K1.0%
American Funds Target Date 2050 Mutual Fund ^$257K0.9%
American Funds Target Date 2040 Mutual Fund ^$152K0.5%
Davis Financial A Mutual Fund ^$144K0.5%
Schwab Government Money Inv Money Market Fund ^$124K0.4%
American Funds Target Date 2060 Mutual Fund ^$113K0.4%
American Funds Target Date 2055 Mutual Fund ^$108K0.4%
American Funds Target Date 2025 Mutual Fund ^$91K0.3%
American Funds Target Date 2035 Mutual Fund ^$74K0.2%
American Funds Target Date 2015 Mutual Fund ^$60K0.2%
JPM Emerging Markets R6 Mutual Fund ^$51K0.2%
American Funds Target Date 2010 Mutual Fund ^$24K<0.1%
Invesco Real Estate A Mutual Fund ^$18K<0.1%
American Funds Target Date 2020 Mutual Fund ^$2K<0.1%